Novo Nordisk launches Wegovy subscription for GLP-1 anti-obesity drugs
Wegovy semaglutide tablets. Michael Siluk | Universal Image Group | fake images Nordisk on Tuesday launched a multi-month subscription program…
Biotechnology and pharmaceuticals
Eli Lilly reaches agreement to bring AI-developed medicines to the global market
A drone view shows the Eli Lilly logo at the company's office in San Diego, California, on November 21, 2025.…
Menstrual product prices soar due to inflation and tariffs
Always products are displayed on a shelf in a supermarket in Sarajevo, Bosnia and Herzegovina, on October 29, 2024. Ruvic…
Eli Lilly's obesity drug retatrutide passes late-stage diabetes trial
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
How CNBC Cures is bringing rare disease stories to a national audience
Last summer, my sister Becky approached me with an idea. He wanted my help to build a platform on CNBC…
FDA approves high-dose version of Novo Nordisk's anti-obesity drug Wegovy
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, on February…
J&J's Icotyde Psoriasis Pill Rivals Tremfya Skyrizi IL-23 Injections
Signs outside the Johnson & Johnson offices in Irvine, California, U.S., on Friday, October 10, 2025. Kyle Grillot Bloomberg |…
Stopping GLP-1 increases cardiovascular risks: study
In a pharmacy you see boxes of Ozempic and Wegovy manufactured by Novo Nordisk. Hollie Adams | Reuters A version…
Vertex kidney drug Povetacicept succeeds in IgAN trial
A sign hangs in front of Vertex Pharmaceuticals' global headquarters in Boston. Brian Snyder | Reuters Vertex Pharmaceuticals said its…
FDA approves leucovorin for brain folate deficiency, but not autism
The Food and Drug Administration on Tuesday approved a decades-old prescription vitamin called leucovorin as the first treatment for a…